The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SB221: A proof-of-concept study to assess the combination of SON-1010 (IL12-FHAB) and atezolizumab in patients with platinum-resistant ovarian cancer.
 
Sant P. Chawla
Stock and Other Ownership Interests - AADi; Cellestia Biotech; Counterpoint; Immix BioPharma
Honoraria - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma; Tyme
Consulting or Advisory Role - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Bo Gao
Consulting or Advisory Role - BeiGene; IMPAC Medical Systems; IMPAC Medical Systems; MSD
 
Carolyn L. Bampton
Stock and Other Ownership Interests - Integrated Clinical Oncology Network
Research Funding - ICON Institute of Innovation and Research
Travel, Accommodations, Expenses - Roche
 
Brett Hamilton
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
John K. Cini
Employment - Sonnet
Leadership - Sonnet
Stock and Other Ownership Interests - Sonnet
Patents, Royalties, Other Intellectual Property - Sonnet
Travel, Accommodations, Expenses - Sonnet
 
Susan Dexter
Employment - Sonnet Biotherapeutics, Inc.
Leadership - Sonnet Biotherapeutics, Inc.
Stock and Other Ownership Interests - Sonnet Biotherapeutics, Inc.
 
Richard T. Kenney
Employment - Public Health Vaccines; Sonnet
Leadership - Sonnet
Stock and Other Ownership Interests - Marker Therapeutics; Sonnet
Travel, Accommodations, Expenses - Sonnet
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Seagen; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; Immunogen; Legend Biotech; Merck; Mersana; Regeneron; Seattle Genetics/Astellas; Sonnet; Sonnet; Tesaro
Speakers' Bureau - Curio Science; OncLive/MJH Life Sciences
Research Funding - Anixa Biosciences (Inst); Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - Eisai
Other Relationship - AstraZeneca; GlaxoSmithKline/Tesaro